Mohammadsadra Shamohammadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammadsadra Shamohammadi has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
Armaghan Abbasi Garavand
9 shared publications- Mansour Bahardoust
Department of epidemiology, School of public health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5 shared publications - Danyal Yarahmadi
Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 shared publications Fatemeh Naseri Rad
Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 shared publicationsMeisam Haghmoradi
Urmia University of Medical Sciences Urmia West Azerbaizan Iran
4 shared publicationsMansour Bahardoust
3 shared publications
Latest Publications
- Open Access
Prognostic significance of the C-reactive protein–albumin–lymphocyte (CALLY) index in primary lung malignancies: a systematic review and meta-analysis with GRADE assessment
Background: The C-reactive protein–albumin–lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune function. We evaluated its association with survival in primary lung malignancies. Methods: Embase, PubMed, Scopus, and Web of Science were searched from inception to 18 September 2026. Risk of bias was assessed using the Quality In Prognosis Studies tool. Hazard ratios (HRs) were synthesized using random-effects models with restricted maximum likelihood estimation and Hartung–Knapp adjustment. Sensitivity analyses, subgroup analyses, and meta-regression examined robustness and heterogeneity. Results: Eleven studies contributed 13 cohorts to the overall survival (OS) analysis and 8 cohorts from seven studies to a combined recurrence/progression-free survival (RFS/PFS) analysis. Lower CALLY was associated with poorer OS (HR 1.78, 95% CI 1.49–2.12; I²=71.6%) and poorer RFS/PFS (HR 1.60, 95% CI 1.40–1.84; I²=0%). Associations persisted in leave-one-out analyses. No statistically significant subgroup differences were detected. Funnel-plot asymmetry suggested small-study effects for OS and RFS/PFS. Seven studies had moderate and four had high overall risk of bias. The certainty of evidence was rated as low for both OS and RFS/PFS, primarily due to risk of bias, heterogeneity, and endpoint indirectness. Conclusion: Lower CALLY was associated with adverse survival outcomes in the current synthesis. Methodological limitations and variation in biomarker measurement and endpoint definitions restrict interpretation. Prospective validation using standardized measurements and clinically coherent outcomes is needed to establish incremental prognostic value and clinical utility.
Open AccessPrognostic significance of the C-reactive protein–albumin–lymphocyte (CALLY) index in primary lung malignancies: a systematic review and meta-analysis with GRADE assessment
Background: The C-reactive protein–albumin–lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune function. We evaluated its association with survival in primary lung malignancies. Methods: Embase, PubMed, Scopus, and Web of Science were searched from inception to 18 September 2026. Risk of bias was assessed using the Quality In Prognosis Studies tool. Hazard ratios (HRs) were synthesized using random-effects models with restricted maximum likelihood estimation and Hartung–Knapp adjustment. Sensitivity analyses, subgroup analyses, and meta-regression examined robustness and heterogeneity. Results: Eleven studies contributed 13 cohorts to the overall survival (OS) analysis and 8 cohorts from seven studies to a combined recurrence/progression-free survival (RFS/PFS) analysis. Lower CALLY was associated with poorer OS (HR 1.78, 95% CI 1.49–2.12; I²=71.6%) and poorer RFS/PFS (HR 1.60, 95% CI 1.40–1.84; I²=0%). Associations persisted in leave-one-out analyses. No statistically significant subgroup differences were detected. Funnel-plot asymmetry suggested small-study effects for OS and RFS/PFS. Seven studies had moderate and four had high overall risk of bias. The certainty of evidence was rated as low for both OS and RFS/PFS, primarily due to risk of bias, heterogeneity, and endpoint indirectness. Conclusion: Lower CALLY was associated with adverse survival outcomes in the current synthesis. Methodological limitations and variation in biomarker measurement and endpoint definitions restrict interpretation. Prospective validation using standardized measurements and clinically coherent outcomes is needed to establish incremental prognostic value and clinical utility.
- Open Access
- 14 October 2026
- Published by Springer Nature in Discover Oncology
Hyperthermic intraperitoneal chemotherapy in hepatocellular carcinoma with peritoneal metastasis or following spontaneous rupture
- 14 October 2026
- Published by Springer Nature in Discover Oncology
Open AccessHyperthermic intraperitoneal chemotherapy in hepatocellular carcinoma with peritoneal metastasis or following spontaneous rupture
- Open Access
- 13 October 2026
- Published by Springer Nature in Discover Oncology
Site- and assay-specific prognostic and treatment-response evidence for HEPACAM2 in colorectal cancer: a systematic scoping review
- 13 October 2026
- Published by Springer Nature in Discover Oncology
Open AccessSite- and assay-specific prognostic and treatment-response evidence for HEPACAM2 in colorectal cancer: a systematic scoping review
- Open Access
- 26 September 2026
- Published by Springer Nature in World Journal of Surgical Oncology
Diagnostic accuracy of droplet digital PCR for BRAF mutation detection in thyroid specimens: a systematic review and meta-analysis
- 26 September 2026
- Published by Springer Nature in World Journal of Surgical Oncology
Open AccessDiagnostic accuracy of droplet digital PCR for BRAF mutation detection in thyroid specimens: a systematic review and meta-analysis
- Open Access
- 31 August 2026
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 16 (4)
Machine Learning-Based Prediction Models for Post-anesthesia Induction Hypotension: A Systematic Review and Meta-Analysis
Context: Post-induction hypotension (PIH), defined as a fall in arterial blood pressure between induction of general anesthesia and surgical incision, accounts for a substantial proportion of intraoperative hypotension and is associated with postoperative organ injury. Machine learning (ML) models have been proposed to identify patients at risk, but their performance, validation, and clinical readiness have not been appraised specifically for this prediction task. Evidence Acquisition: In this systematic review and meta-analysis, reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement, PubMed, Embase, Scopus, and Web of Science were searched from inception to 4 October 2025 for studies that developed or validated Machine learning (ML) models predicting PIH in adults under general anesthesia. Risk of bias was assessed with the Prediction model Risk Of Bias ASsessment Tool. For each study, we extracted the best-performing model and its most independent validation estimate. Areas under the receiver operating characteristic curve (area under the receiver operating characteristic curve (AUC)) were pooled on the logit scale with a restricted maximum-likelihood random-effects model, Hartung-Knapp-Sidik-Jonkman confidence intervals (CIs), and 95% prediction intervals, using one estimate per independent cohort. Sensitivity and specificity were pooled jointly with a bivariate random-effects model. Results: Ten reports (eight independent cohorts; 238,123 participants across reports, including overlapping samples) were included. No model had undergone geographic external validation, and calibration was reported for three models. The pooled AUC was 0.78 (95% CI 0.70 - 0.84; k = 8), with marked between-study heterogeneity (I2 = 97.7%) and a 95% prediction interval of 0.52 - 0.92. The summary sensitivity and specificity were 0.72 (95% CI 0.67 - 0.77) and 0.76 (95% CI 0.68 - 0.82), respectively (k = 6). Estimates were similar across sensitivity analyses, but the pooled AUC fell to 0.74 (95% CI 0.65 - 0.81) when the median-performing, rather than best-performing, model from each study was analyzed. Model families did not differ significantly (P = 0.59). Nine of the ten reports were at high overall risk of bias. Discussion: Published machine learning (ML) models show moderate discrimination for PIH, but their performance in a new setting is highly uncertain. The evidence is limited by a high risk of bias, heterogeneous outcome definitions and prediction horizons, optimistic validation, and sparse calibration reporting. These pooled estimates should not be interpreted as evidence of clinical readiness; multicenter external validation, including calibration and clinical utility assessment, and impact studies are required.
- 31 August 2026
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 16 (4)
Open AccessMachine Learning-Based Prediction Models for Post-anesthesia Induction Hypotension: A Systematic Review and Meta-Analysis
Context: Post-induction hypotension (PIH), defined as a fall in arterial blood pressure between induction of general anesthesia and surgical incision, accounts for a substantial proportion of intraoperative hypotension and is associated with postoperative organ injury. Machine learning (ML) models have been proposed to identify patients at risk, but their performance, validation, and clinical readiness have not been appraised specifically for this prediction task. Evidence Acquisition: In this systematic review and meta-analysis, reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement, PubMed, Embase, Scopus, and Web of Science were searched from inception to 4 October 2025 for studies that developed or validated Machine learning (ML) models predicting PIH in adults under general anesthesia. Risk of bias was assessed with the Prediction model Risk Of Bias ASsessment Tool. For each study, we extracted the best-performing model and its most independent validation estimate. Areas under the receiver operating characteristic curve (area under the receiver operating characteristic curve (AUC)) were pooled on the logit scale with a restricted maximum-likelihood random-effects model, Hartung-Knapp-Sidik-Jonkman confidence intervals (CIs), and 95% prediction intervals, using one estimate per independent cohort. Sensitivity and specificity were pooled jointly with a bivariate random-effects model. Results: Ten reports (eight independent cohorts; 238,123 participants across reports, including overlapping samples) were included. No model had undergone geographic external validation, and calibration was reported for three models. The pooled AUC was 0.78 (95% CI 0.70 - 0.84; k = 8), with marked between-study heterogeneity (I2 = 97.7%) and a 95% prediction interval of 0.52 - 0.92. The summary sensitivity and specificity were 0.72 (95% CI 0.67 - 0.77) and 0.76 (95% CI 0.68 - 0.82), respectively (k = 6). Estimates were similar across sensitivity analyses, but the pooled AUC fell to 0.74 (95% CI 0.65 - 0.81) when the median-performing, rather than best-performing, model from each study was analyzed. Model families did not differ significantly (P = 0.59). Nine of the ten reports were at high overall risk of bias. Discussion: Published machine learning (ML) models show moderate discrimination for PIH, but their performance in a new setting is highly uncertain. The evidence is limited by a high risk of bias, heterogeneous outcome definitions and prediction horizons, optimistic validation, and sparse calibration reporting. These pooled estimates should not be interpreted as evidence of clinical readiness; multicenter external validation, including calibration and clinical utility assessment, and impact studies are required.
- Open Access
- 4 July 2026
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 19 (1)
Safety and efficacy of chest tube clamping versus non-clamping prior to removal: a systematic review and meta-analysis
Managing chest tubes before removal remains a controversial clinical issue. Clamping a chest tube before removal is a common practice and is often used to assess latent air leaks. We systematically searched MEDLINE/PubMed, Embase, Scopus, and Web of Science from inception to 11 February 2026 for studies comparing clamping versus no clamping before chest-tube removal. Two reviewers independently screened and extracted data. Random effect meta-analyses used REML with Hartung-Knapp adjustment, pooling risk ratios for pneumothorax and re-intervention, and mean differences (days) for hospital length of stay. The results of this study show no significant differences between the clamping vs. no-clamping in terms of pneumothorax/hemothorax recurrence, re-intervention rates, or hospital length of stay. Within different causes of applying chest tube/ chest drain, routine clamping before chest-tube removal did not reduce early recurrence or the need for re-intervention.
- 4 July 2026
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 19 (1)
Open AccessSafety and efficacy of chest tube clamping versus non-clamping prior to removal: a systematic review and meta-analysis
Managing chest tubes before removal remains a controversial clinical issue. Clamping a chest tube before removal is a common practice and is often used to assess latent air leaks. We systematically searched MEDLINE/PubMed, Embase, Scopus, and Web of Science from inception to 11 February 2026 for studies comparing clamping versus no clamping before chest-tube removal. Two reviewers independently screened and extracted data. Random effect meta-analyses used REML with Hartung-Knapp adjustment, pooling risk ratios for pneumothorax and re-intervention, and mean differences (days) for hospital length of stay. The results of this study show no significant differences between the clamping vs. no-clamping in terms of pneumothorax/hemothorax recurrence, re-intervention rates, or hospital length of stay. Within different causes of applying chest tube/ chest drain, routine clamping before chest-tube removal did not reduce early recurrence or the need for re-intervention.
- Open Access
- 22 April 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70208
Gestational Diabetes and Long‐Term Risk of Maternal Kidney Disease: Systematic Review and Meta‐Analysis of Population Base Cohort Studies
Background: Gestational diabetes mellitus (GDM) may increase the risk of maternal chronic kidney disease (CKD). The association of GDM with maternal CKD has been heterogeneous across studies, and this association remains controversial. The aim of this systematic review was to investigate the association of GDM with the risk of maternal CKD. Methods: MEDLINE/PubMed, EMBASE, Scopus and Web of Science were searched, with no time limit, up to 25 August 2025 by two independent investigators to identify studies that had assessed the association of GDM with maternal risk of CKD. Heterogeneity between studies was assessed using Cochrane's Q and I2 tests. Meta‐regression was performed to identify factors associated with heterogeneity. Results: Eleven cohort studies involving 21,313,434 participants (1,530,599 (7.2%) GDM) were included. Pooled estimates from eleven studies showed that GDM was significantly associated with an increased risk of maternal CKD (HR: 2.19; 95% CI: 1.7, 2.68; p: 0.001, I 2 :92.2%). Further analyses restricted to studies adjusting for key confounders (HR: 2.47; 95% CI: 1.87, 3.08; p: 0.001, I2:24.2%) also showed a significant association. While pooled estimates from three studies did not show a significant association between GDM and an increased risk of AKI (HR: 1.1; 95% CI: 0.94, 1.26). Subgroup analyses showed that GDM was significantly associated with an increased risk of maternal CKD in both DM + (HR: 6.24) and DM ‐ (HR: 1.4). Conclusion: Gestational diabetes mellitus (GDM) with and without DM was significantly associated with an increased risk of maternal CKD. GDM with DM had a synergistic effect on maternal CKD risk. Although GDM was not significantly associated with increased AKI, only three studies were included in the AKI analysis, which may have affected these results by random error and therefore lack sufficient power and evidence to draw conclusions.
- 22 April 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70208
Open AccessGestational Diabetes and Long‐Term Risk of Maternal Kidney Disease: Systematic Review and Meta‐Analysis of Population Base Cohort Studies
Background: Gestational diabetes mellitus (GDM) may increase the risk of maternal chronic kidney disease (CKD). The association of GDM with maternal CKD has been heterogeneous across studies, and this association remains controversial. The aim of this systematic review was to investigate the association of GDM with the risk of maternal CKD. Methods: MEDLINE/PubMed, EMBASE, Scopus and Web of Science were searched, with no time limit, up to 25 August 2025 by two independent investigators to identify studies that had assessed the association of GDM with maternal risk of CKD. Heterogeneity between studies was assessed using Cochrane's Q and I2 tests. Meta‐regression was performed to identify factors associated with heterogeneity. Results: Eleven cohort studies involving 21,313,434 participants (1,530,599 (7.2%) GDM) were included. Pooled estimates from eleven studies showed that GDM was significantly associated with an increased risk of maternal CKD (HR: 2.19; 95% CI: 1.7, 2.68; p: 0.001, I 2 :92.2%). Further analyses restricted to studies adjusting for key confounders (HR: 2.47; 95% CI: 1.87, 3.08; p: 0.001, I2:24.2%) also showed a significant association. While pooled estimates from three studies did not show a significant association between GDM and an increased risk of AKI (HR: 1.1; 95% CI: 0.94, 1.26). Subgroup analyses showed that GDM was significantly associated with an increased risk of maternal CKD in both DM + (HR: 6.24) and DM ‐ (HR: 1.4). Conclusion: Gestational diabetes mellitus (GDM) with and without DM was significantly associated with an increased risk of maternal CKD. GDM with DM had a synergistic effect on maternal CKD risk. Although GDM was not significantly associated with increased AKI, only three studies were included in the AKI analysis, which may have affected these results by random error and therefore lack sufficient power and evidence to draw conclusions.